Naturally occurring sesquiterpene lactone dimers (SLDs) are a type of complex found in natural products with many pharmacological activities[@b1][@b2]. Since the first SLD absinthin was isolated from *Artemisia absinthium* in 1953[@b3], more than 160 SLDs have been obtained. To the best of our knowledge, most of the published SLDs have C~30~ cores derived from two C~15~ sesquiterpenoid units[@b4][@b5][@b6].

The genus *Vladimiria,* belonging to the family of Asteraceae, comprises approximately 12 species that are mainly distributed in the Sichuan Province, China[@b7]. Sesquiterpenes, as major constituents isolated from the *Vladimiria* species, possess various types of structures including guaianolide, carabrane, eudesmane and germacrane sesquiterpenes[@b8][@b9][@b10][@b11][@b12]. The plant of *Vladimiria souliei*, as a traditional Chinese medicine, has been used for relieving pain and stomach diseases since ancient times[@b7][@b13]. Additionally, the chemical constituents from the roots of *V. souliei* exhibited significant antimicrobial, antitumor and inhibitory effects on NO production activities[@b10][@b13]. In the course of our investigation on structurally novel SLDs from the family of Asteraceae, four rare SLDs with C~32~ cores were discovered from *Vladimiria souliei*, and they were designated vlasouliolides A-D (**1**--**4**) ([Fig. 1](#f1){ref-type="fig"}).

Results and Discussion
======================

Structure elucidation
---------------------

Vlasouliolide A (**1**), +3.77 (*c* 0.24, CH~3~COCH~3~), was obtained as a colorless orthorhombic crystal. Its molecular formula was determined to be C~32~H~40~O~5~ by positive HRESIMS at *m/z* 527.2763 (\[M + Na\]^+^, calcd. 527.2773). The ^1^H NMR spectrum of **1** ([Supplementary Table S1](#S1){ref-type="supplementary-material"}) showed characteristic signals for one methyl singlet at *δ*~H~ 2.16 (3H, s, -Ac), two oxymethines at *δ*~H~ 3.91 (1H, t, *J* = 9.5 Hz, H-6′) and *δ*~H~ 4.17 (1H, t, *J* = 9.6 Hz, H-6), and four sets of terminal alkylene (*δ*~H~ 4.83, 1H, s, 4.76, 1H, s, H~2~-14; *δ*~H~ 4.88, 1H, s, 4.78, 1H, s, H~2~-14′; *δ*~H~ 5.29, 1H, d, *J* = 1.8 Hz, 5.06, 1H, d, *J* = 1.7 Hz, H~2~-15; *δ*~H~ 5.14, 1H, d, *J* = 1.9 Hz, 5.03, 1H, d, *J* = 1.7 Hz, H~2~-15′).

Analysis of the ^13^C NMR spectrum revealed the existence of 32 carbons ([Supplementary Table S2](#S1){ref-type="supplementary-material"}), including 1 × CH~3~, 14 × CH~2~ (containing 4 sp^2^ alkylenes at *δ*~C~ 109.3, 109.6, 111.6, and 112.0), 9 × CH (containing 2 oxymethines at *δ*~C~ 82.4 and 84.5), and 8 × C (containing 3 carbonyl carbons at *δ*~C~ 177.5, 178.3 and 205.2). Detailed analysis of the NMR spectrum of **1** indicated that vlasouliolide A (**1**) should contain an acetyl due to the resonance signals at *δ*~C~ 205.2, 30.7, and *δ*~H~ 2.16 (3H, s, -Ac). Deducting the carbon resonances for the acetyl, the remaining 30 carbon resonances implied that two similar sesquiterpene lactone units existed.

The planar structure of vlasouliolide A was constructed by comprehensive analyses of the 2D NMR spectra ([Fig. 2A](#f2){ref-type="fig"}). Two similar long proton-bearing structural fragments, H~2~-3/H~2~-2/H-1/H-5/H-6/H-7/H~2~-8/H~2~-9 and H~2~-3′/H~2~-2′/H-1′/H-5′/H-6′/H-7′/H~2~-8′/H~2~-9′, as well as an extra short chain, H-7′/H-11′/H~2~-13′, were constructed based on interpretation of the ^1^H-^1^H COSY and HSQC-TOCSY spectra. The HMBC spectrum of **1** showed the key correlations of four typical terminal alkylene groups ([Fig. 2A](#f2){ref-type="fig"}), including H~2~-14/C-1 and C-9; H~2~-15/C-3 and C-5; H~2~-14′/C-1′ and C-9′; and H~2~-15′/C-3′ and C-5′. Thus, subunits A and B were deduced to be two guaianolide moieties similar to dehydrocostus lactone[@b14][@b15]. Therefore, the structure of **1** should be composed of two guaianolide moieties and an acetyl moiety. In the HMBC spectrum of **1**, the long correlations from H~3~-17 (*δ*~H~ 2.16, 3H, s) to C-13 (*δ*~C~ 46.4) as well as H~2~-13 (*δ*~H~ 2.86, 2.56, 1H, d, *J* = 19 Hz, respectively) to C-7 (*δ*~C~ 48.2) and C-12 (*δ*~C~ 178.3) indicated that the acetyl moiety was connected to the C-13 position of one guaianolide unit. Compared with dehydrocostus lactone, the C-11 position of subunit A was a quaternary carbon, while the C-13′ position of subunit B was an sp^3^ methylene. These changes implied that the two sesquiterpene lactone units should be linked directly *via* a C-C bond between C-11 and C-13′, and this assumption was verified by the HMBC correlations of H~2~-13′ (*δ*~H~ 2.23, 1.35, 1H, m, respectively) with C-11 (*δ*~C~ 46.1), C-12 (*δ*~C~ 178.3), C-11′ (*δ*~C~ 41.9) and C-12′ (*δ*~C~ 177.5). Thus, the planar structure of **1** was elucidated as shown in [Fig. 1](#f1){ref-type="fig"}.

The relative configuration of **1** was characterized by interpretation of the NOESY spectrum ([Fig. 2A](#f2){ref-type="fig"}). The similar NOESY correlations of H-1/H-7/H-5 and H-1′/H-7′/H-5′ in subunits A and B indicated that they are on the same face. In addition, the large coupling constant between H-6/H-7 and H-6′/H-7′ (*J* = 9.6, 9.5 Hz, respectively) implied that H-6/H-7 and H-6′/H-7′ were in the *trans*-form. Consequently, in subunit A, H-7 was arbitrarily assigned as having an *α*-orientation. The correlation between H-7 and H~2~-13 suggested that the side chain C~13~/C~16~/C~17~ should be located below the molecular plane. Thus, the H~2~-13′ was assigned as having a *β*-orientation, as indicated by the NOESY correlations of H-6 with H~2~-13′. It should be noted that H~2~-13′ exhibited NOESY correlations with H-7′. Combined with the NOESY correlation between H~2~-13 and H-11′, the relative configuration of H-11′ should be the *α*-orientation. Finally, the absolute configuration of **1** was confirmed to be 1*R*, 5*R*, 6*S*, 7*S*, 11*S*, 1′*R*, 5′*R*, 6′*S*, 7′*S*, 11′*S* by Cu-Κ*α* X-ray crystallographic analysis ([Fig. 2B](#f2){ref-type="fig"}).

Vlasouliolide B (**2**), +20.41 (*c* 0.21, CH~3~COCH~3~), possessed the same molecular formula as that of **1** as determined by positive HRESIMS at *m/z* 527.2758 (\[M + Na\]^+^, calcd. 527.2773). Analysis of the NMR data ([Supplementary Tables S1 and S2](#S1){ref-type="supplementary-material"}) indicated that compound **2** possesses the same planar structure as that of **1**. The notable NOESY correlation of H~2~-13/H-11′/H-7′ in **2** instead of that H-11′/H-6′ in **1** implied that **2** was an 11′-epimer of **1**. Comparing the NMR spectroscopic data of **2** with those of **1**, an obvious downfield shift of Ha-13 from *δ*~H~ 2.86 in **1** to *δ*~H~ 3.36 in the ^1^H NMR was observed. As shown in [Fig. 3A](#f3){ref-type="fig"}, the opposite arrangement of the two subunits led to the C-12′ carbonyl and H~2~-13 in **1** being far from each other. In contrast, the subunits A and B were arranged in the same direction in **2**, resulting in the H~2~-13 being spatially adjacent to the carbon-oxygen double bond at C-12′. Thus, the intramolecular deshielding effect contributed to the downfield shift of Ha-13 from *δ*~H~ 2.86 in **1** to *δ*~H~ 3.36 in **2**. Finally, the absolute configuration of C-11′ was confirmed as *R* by Cu-Κ*α* X-ray diffraction ([Fig. 3B](#f3){ref-type="fig"}).

Vlasouliolide C (**3**) was isolated as a colorless monoclinic crystal with +30.23 (*c* 0.04, CHCl~3~). Its molecular formula was determined to be C~32~H~42~O~5~ by positive HRESIMS at *m/z* 529.2940 (\[M + Na\]^+^, calcd. 529.6728). The 1D NMR data ([Supplementary Tables S1 and S2](#S1){ref-type="supplementary-material"}) of **3** disclosed a C~32~ skeleton similar to in **1** and **2**. Comprehensive analysis of the 2D NMR spectra indicated that compound **3** possessed the same 13-acetyl-mokkolactone fragment (subunit A) as **1** and **2**. Unlike the structures of **1** and **2**, an eudesmane moiety existed as subunit B in the structure of **3**, as deduced by the ^1^H-^1^H COSY correlations of H~2~-3′/H~2~-2′/H-1′, H-5′/H-6′/H-7′/H~2~-8′/H~2~-9′ and H-7′/H-11′/H~2~-13′ together with crucial HMBC correlations from H~2~-15′ to C-3′ and C-5′ as well as from CH~3~-14 to C-1, C-2, and C-9. Therefore, the structure of **3** was formed by an acetyl-substituted guaianolide moiety and eudesmane moiety. The HMBC correlations from H~2~-13′ (*δ*~H~ 2.30, 1.38) to C-11′ (*δ*~C~ 41.6), C-12′ (*δ*~C~ 178.8), C-11 (*δ*~C~ 46.2), C-12 (*δ*~C~ 178.3) and C-13 (*δ*~C~ 47.2) suggested that subunits A and B should also be directly linked by a C-11/13′ single bond ([Fig. 4A](#f4){ref-type="fig"}).

The relative configuration of subunit B was deduced by analysis of the NOESY correlations ([Fig. 4A](#f4){ref-type="fig"}). H-11′, H-6′ and H-14′ were assigned as having the *α*-orientation, and H-5′, H-7′ and H-13′ were assigned as having the *β*-orientation, which were consistent with the biosynthetic precursor *β*-cyclocostunolide[@b16]. Similar to **1**, the opposite arrangement of the two subunits was verified by the NOESY correlations of H-13′/H-6 and H-11′/H-13. The structure of **3** was finally elucidated as shown in [Fig. 1](#f1){ref-type="fig"}, and the absolute configuration was assigned as 1*R*, 5*R*, 6*S*, 7*S*, 11*S*, 5′*S*, 6′*S*, 7′*S*, 10′*S*, 11′*S* by Cu-Κ*α* X-ray crystallographic analysis ([Fig. 4B](#f4){ref-type="fig"}).

Vlasouliolide D (**4**), a colorless orthorhombic crystal with +55.21 (*c* 0.08, CH~3~COCH~3~), possessed the same molecular formula as that of **3** determined by positive HRESIMS at *m/z* 529.2923 (\[M + Na\]^+^ calcd. 529.6722). The 1D NMR data of **4** ([Supplementary Tables S1 and S2](#S1){ref-type="supplementary-material"}) revealed that **4** was constructed from one acetyl, one dehydrocostus lactone, and one *β*-cyclocostunolide moieties, which were identical with those of **3**. However, different from **3**, the acetyl in **4** was located at the C-13 position of *β*-cyclocostunolide to form 13-acetyl-eudesmenolide (subunit A), which is supported by the key HMBC correlations from H~2~-13 (*δ*~H~ 2.79, 2.66, 1H, d, *J* = 17 Hz, respectively) to C-7 (*δ*~C~ 51.9), C-11 (*δ*~C~ 46.2) and C-12 (*δ*~C~ 178.9). Subunit B was also connected to subunit A *via* a C-11/13′ single bond. Therefore, the structure of **4** was determined as shown in [Fig. 1](#f1){ref-type="fig"}. The absolute configuration of **4** was determined as 5*S*, 6*S*, 7*S*, 10*R*, 11*S*, 1′*R*, 5′*R*, 6′*S*, 7′*S*, 11′*S* by Cu-Κ*α* X-ray crystallographic analysis ([Fig. 5](#f5){ref-type="fig"}).

Biological activity assay
-------------------------

The roots of *V. souliei* are often used in traditional Chinese medicine for the treatment of digestive disorders and inflammatory diseases. Many sesquiterpenes isolated from *V. souliei* showed inhibitory activity against lipopolysaccharide (LPS)-induced nitric oxide (NO) production in murine RAW264.7 cells[@b10]. Excessive NO has been implicated in the pathological process of tissue damage following inflammation[@b17]. The inhibition of the overproduction of NO is an important therapeutic way to treat inflammatory diseases[@b18]. We investigated the anti-inflammatory activities of compounds **1**--**4** by a LPS-induced NO production assay in RAW 264.7 macrophages[@b5]. Compounds **1**--**4** exhibited significant inhibitory effects against NO production with IC~50~ values of 1.14, 2.53, 1.57 and 3.19 *μ*M, respectively. Moreover, these compounds were not notably cytotoxic at the concentrations required for inhibiting NO production, as determined by an MTT assay. NF-*κ*B is a transcription factor that controls immune responses and plays a pivotal role in the regulation of NO expression[@b19]. We conducted an NF-*κ*B luciferase reporter assay in 293T cells to evaluate the impact of compounds **1**--**4** on the transcriptional activity of NF-*κ*B[@b20].

The NF-*κ*B reporter luciferase construct and Renilla luciferase control vector were cotransfected in 293T cells for 24 h. Thereafter, the cells were left untreated or were treated with a 10 *μ*M concentration of compound for an additional 1 h before LPS activation for 4 h. Compounds **1** and **2** displayed inhibition towards the NF-*κ*B pathway, while **3** and **4** showed no effects in the reduction of NF-*κ*B luciferase activity ([Fig. 6A](#f6){ref-type="fig"}). We also examined the effects of compounds **1**--**4** on the expression of I*κ*B*α* and P65 proteins in the NF-*κ*B pathway[@b21]. RAW 264.7 cells pretreated with **1**--**4** at the indicated concentrations for 1 h were subjected to LPS stimulation before Western blot analysis. Compounds **1**--**4** had no inhibitory effects on the degradation of I*κ*B*α*, while **1** and **2** can dose-dependently down-regulate the LPS-induced phosphorylation of the NF-*κ*B p65 subunit ([Fig. 6B](#f6){ref-type="fig"}). These data indicated that the NO inhibitory activities of **1** and **2** might be attributed to suppressing NF-*κ*B activation, while those of **3** and **4** might not be due to this mechanism.

In conclusion, sesquiterpene lactone dimers usually have a C~30~ framework biosynthetically derived from a Diels-Alder adduct of two homo or hetero sesquiterpene monomers. Vlasouliolides A-D (**1**--**4**) possessed a C~32~ skeleton derived from two sesquiterpene lactone molecules and an acetyl group. Commonly, in the chemical structures of **1**--**4**, the acetyl was connected to the C-13 of one of the two sesquiterpene lactone units to form a C~17~ unit, and the C~17~/C~15~ units were further directly linked by a C11-C13′ single bond. This is the first report regarding C~17~/C~15~ sesquiterpene lactone dimers from nature with significant anti-inflammation activities, which might be potentially useful for the treatment of inflammatory diseases. The discovery of Vlasouliolides A-D may encourage further investigations by natural product chemists, synthetic chemists, and pharmacists.

Methods
=======

General experimental procedures
-------------------------------

Column chromatography (CC): silica gel H (10--40 *μ*m) and silica gel (200--300 mesh) (Marine Chemical Factory, Qingdao, P. R. China); Sephadex LH-20 (Pharmacia Fine Chemicals, Piscataway, NJ, USA); RP-C18 gel (40−63 *μ*m; Daiso, Co., Japan). TLC: silica gel plates (Yantai Jiang You Silicone Development Co., Yantai, P. R. China), visualization by spraying with 10% H~2~SO~4~ in EtOH. HPLC: Agilent 1260 series (Agilent Technologies, US) with a Zorbax SB-C18 (5 *μ*m, 9.4 × 150 mm) column. NMR: Bruker Avance III-500 and Avance III-600 spectrometers (Bruker, Switzerland). MS: Agilent MSD-Trap-XCT (for ESI) and Agilent-6520 Q-TOF mass spectrometers (for HR-ESI). Melting point: X-4B digital display micro-melting apparatus (Shanghai Jingsong Instrument, Shanghai, P. R. China). Optical rotation: Rudolph Autopo V (Rudolph Research Analytical, Hackettstown, NJ). UV: Agilent 1260 series DAD detector (Agilent Technologies, US). CD: Brighttime Chirascan (Applied Photophysics Ltd, UK). IR: Thermo Scientific Nicolet 6700 (Thermo Scientific, USA). RAW 264.7 cells and 293T cells: ATCC (American type culture collection). Dulbecco's modified Eagle's medium and fetal bovine serum: Gibco Invitrogen (Carlsbad, CA, USA). LPS Griess reagent and MTT: Sigma-Aldrich (St. Louis, MO, USA).

Plant material
--------------

The roots of *V. souliei* were collected from the Sichuan province of China in October 2014 and authenticated by professor Bao-Kang Huang, Department of Pharmacognosy, School of Pharmacy, Second Military Medical University. A voucher specimen (No. 201412-VS) is deposited in the Department of Pharmacognosy, Second Military Medical University.

Extraction and isolation
------------------------

The chipped and dried roots of *V. souliei* (20.0 kg) were extracted by maceration with 95% ethanol overnight at room temperature (3 × 60 L). After removal of the solvent, the ethanol extract (2.12 kg) was successively partitioned between water and petroleum ether (PE)/ethyl acetate (EtOAc) to give PE, EtOAc and water extracts. The EtOAc extract (0.626 kg) was segmented by silica gel column chromatography (PE/EtOAc, 50:1--0:1) to yield 17 fractions (Fr. 1--17). Fraction 7 (31.99 g) underwent chromatography over an RP-C18 medium-pressure column (MeOH/H~2~O, 10:90 to 90:10) to give 12 subfractions (Fr. 7.1--7.12). Subfraction 7.9 (2.5 g) underwent further chromatography over an RP-C18 medium-pressure column (CH~3~CN/H~2~O, 45:55) and was finally purified by semi-preparative RP-C18 HPLC (MeOH/H~2~O, 71:29) to produce **1** (42.9 mg) and **4** (5.2 mg). Subfraction 7.10 (1.89 g) underwent chromatography over an RP-C18 medium-pressure column using MeOH/H~2~O (55:45--100:0) as the elution solvent, and the 70--80% fraction was purified by semi-preparative RP-C18 HPLC (CH~3~CN/H~2~O, 45:55), yielding **2** (22.2 mg). Fraction 8 (5.40 g) underwent chromatography over an RP-C18 medium-pressure column using MeOH/H~2~O in a gradient (10:90--100:0) to yield eight subfractions (Fr. 8.1--8.8). Subfraction 8.5 (2.35 g) was purified by an RP-C18 medium-pressure column (MeOH/H~2~O, 55:45 to 100:0) followed by semi-preparative RP-C18 HPLC (CH~3~CN/H~2~O, 63:27) to produce **3** (10.6 mg). Overall, we obtained compounds **1** (42.9 mg), **2** (22.2 mg), **3** (10.6 mg) and **4** (5.2 mg).

Spectroscopic data
------------------

**Vlasouliolide A** (**1**) Colorless orthorhombic crystals in EtOH/H~2~O. m.p.: 169--173 °C; +3.77 (*c* 0.24, CH~3~COCH~3~); UV (CH~3~OH/H~2~O) λ~max~ 210 nm; IR (KBr) *ν*~max~ 3089, 2931, 2854, 1770, 1714, 1639, 1446, 1400, 1367, 1334, 1209, 1178, 1126, 995, 890 cm^−1^; ^1^H- and ^13^C-NMR data, see [Tables S1 and S2](#S1){ref-type="supplementary-material"}; ESIMS *m/z* 527.4 (\[M + Na\]^+^), 503.2 (\[M − H\]^−^); positive HRESIMS *m/z* 527.2763 (\[M + Na\]^+^, calcd. 527.2773).

**Vlasouliolide B** (**2**) Colorless orthorhombic crystals in EtOH/H~2~O. m.p.: 171--173 °C; +20.41 (*c* 0.21, CH~3~COCH~3~); UV (CH~3~CN/H~2~O) λ~max~ 210, 254, 290 nm; IR (KBr) *ν*~max~ 3081, 2931, 2854, 1760, 1712, 1641, 1455, 1365, 1313, 1213, 1164, 995, 885 cm^−1^; ^1^H- and ^13^C-NMR data, see [Tables S1 and S2](#S1){ref-type="supplementary-material"}; ESIMS *m/z* 527.3 (\[M + Na\]^+^), 539.3 (\[M + Cl\]^−^); positive HRESIMS *m/z* 527.2758 (\[M + Na\]^+^, calcd. 527.2773).

**Vlasouliolide C** (**3**) Colorless monoclinic crystals in CHCl~3~/MeOH. m.p.: 211--218 °C; +30.23 (*c* 0.04 CHCl~3~); UV (CH~3~CN/H~2~O) λ~max~ 210 nm; IR (KBr) *ν*~max~ 3086, 2929, 2849, 1763, 1719, 1649, 1444, 1380, 1336, 1260, 1195, 1159, 1103, 1019, 991, 911, 891 cm^−1^; ^1^H- and ^13^C-NMR data, see [Tables S1 and S2](#S1){ref-type="supplementary-material"}; ESIMS *m/z* 529.4 (\[M + Na\]^+^), 541.5 (\[M + Cl\]^−^); positive HRESIMS *m/z* 529.2940 (\[M + Na\]^+^, calcd. 529.2930).

**Vlasouliolide D** (**4**) Colorless orthorhombic crystals in EtOH/H~2~O. m.p.: 172--182 °C; +55.21 (*c* 0.08 CH~3~COCH~3~); UV (CH~3~CN/H~2~O) λ~max~ 210 nm; IR (KBr) *ν*~max~ 2933,1772,1712, 1648, 1457, 1367, 1205, 1176, 1130, 995, 892 cm^−1^; ^1^H- and ^13^C-NMR data, see [Tables S1 and S2](#S1){ref-type="supplementary-material"}; ESIMS *m/z* 529.4 (\[M + Na\]^+^), 505.3 (\[M − H\]^−^); positive HRESIMS *m/z* 529.2923 (\[M + Na\]^+^, calcd. 529.2930).

Measurement of LPS-Induced NO Production
----------------------------------------

RAW 264.7 cells were seeded in 96-well culture plates at 5 × 10^5^ cells/well at 37 °C for 6 h in DMEM medium. The cells were pretreated with different concentrations of samples for 12 h and then incubated for 16 h with or without 1 *μ*g/mL LPS. The nitrite concentration in the culture supernatant was measured using Griess reagent (1% sulfanilamide, 0.1% N-1-naphthylenediamine dihydrochloride and 2.5% phosphoric acid). The absorbance was measured at 540 nm using a microplate reader after incubation for 15 min. The nitrite levels in the samples were calculated from a standard curve created using known concentrations of sodium nitrite.

MTT assay
---------

RAW 264.7 cells were seeded in 96-well plates at 5 × 10^5^ cells/well for 6 h and treated with different concentrations of compounds for 24 h. Thereafter, MTT \[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide\] was added to each well at a final concentration of 0.5 mg/ml and incubated at 37 °C for 3 h. The amount of MTT formazan was determined by dissolving it in dimethyl sulfoxide (DMSO) and measuring its absorbance at 495 nm using a microplate reader.

Dual-Luciferase reporter gene assay
-----------------------------------

293T cells were seeded in 24-well plates at 2 × 10^6^ cells/well for 6 h. After being cotransfected with expression plasmids for NF-*κ*B firefly luciferase and TK-Renilla luciferase for 24 h, the cells were treated with 10 *μ*M concentrations of compounds **1**--**4** for an additional 1 h. Thereafter, the cells were stimulated with 1 *μ*g/ml LPS for another 6 h and then lysed in lysis buffer. Luciferase activities were measured by the dual-luciferase reporter gene assay system (Promega). NF-*κ*B firefly luciferase activity was normalized to the *Renilla* luciferase activity.

Antibodies and Western blot analysis
------------------------------------

Antibodies for p-p65, p65, p-I*κ*B*α*, I*κ*B*α* and Gapdh were purchased from Cell Signaling Technology. For western blot analysis, RAW 264.7 cells were lysed in 2× SDS sample buffer (62.5 mM Tris-HCl, pH = 6.8, 2% SDS, 10% glycerol, 50 mM DTT, and 0.01% bromophenol blue) after treatment with the compounds and stimulation by LPS. Cell lysates were fractionated by sodium dodecyl sulfate--polyacrylamide gel electrophoresis (SDS-PAGE) after denaturation treatment and subjected to immunoblot analysis with GAPDH as the loading control.
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![(**A**) The deshielding effect of the carbonyl group at C-12′ and (**B**) X-ray crystallographic structure of **2**.](srep43837-f3){#f3}

![(**A**) Selected NMR correlations and (**B**) X-ray crystallographic structure of **3**.](srep43837-f4){#f4}
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![Effects of **1**--**4** on LPS-stimulated NF-*κ*B activation.\
(**A**) The NF-*κ*B luciferase reporter assay shows that compounds **1** and **2** displayed suppression of LPS-induced NF-*κ*B activation in 293T cells. (Mean ± SD in three separate experiments. \*p \< 0.05; \*\*p \< 0.001). (**B**) The effects of compounds **1**--**4** on the phosphorylation of I*κ*B*α* and p65 in the presence of LPS stimulation in RAW 264.7 cells.](srep43837-f6){#f6}
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